Related Experiment Video

Updated: Oct 3, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

[Inhibitory effect of phosphorothioae oligodeoxynucleotides on HBV replication and synthesis of antigen in vitro]

L Yang1, J Yao, L Deng

  • 1Viral Hepatitis Research Unit, Third Affiliated Hospital, Sun Yat-sen University of Medical Sciences, Guangzhou 510630.

Zhonghua Yi Xue Za Zhi
|November 22, 2001
PubMed
Abstract

Insights

Triplex forming oligodeoxynucleotides (TFO) and antisense oligodeoxynucleotides (ODNas) effectively inhibit hepatitis B virus (HBV) replication and antigen synthesis. These novel nucleic acid therapies demonstrate significant potential for HBV treatment with no observed toxicity.

Area of Science:

  • Molecular Biology
  • Virology
  • Oligonucleotide Therapeutics

Context:

  • Hepatitis B virus (HBV) infection remains a significant global health challenge.
  • Current treatments for HBV have limitations, necessitating the development of novel therapeutic strategies.
  • Oligonucleotide-based therapies offer a promising avenue for targeting viral replication.

Purpose:

  • To investigate the efficacy of triplex forming oligodeoxynucleotides (TFO) and antisense oligodeoxynucleotides (ODNas) in inhibiting HBV replication.
  • To assess the impact of TFO and ODNas on the synthesis of HBV antigens (HBsAg and HBeAg).
  • To evaluate the safety profile of these oligodeoxynucleotides in cell culture models.

Summary:

  • Synthesized and tested a 21-mer phosphorothioate TFO (TFO21) targeting the HBV core promoter and a 21-mer phosphorothioate ODNas (ODNas21) complementary to viral RNA initiation sites.
  • Both TFO21 and ODNas21 demonstrated significant inhibition of HBV replication and antigen synthesis in 22.1.5 cells.
  • A combination of TFO21 and ODNas21 exhibited enhanced inhibitory effects compared to individual treatments, with dose-dependent inhibition and no observed cellular toxicity.

Impact:

  • This study highlights the potent antiviral activity of TFO and ODNas against HBV replication.
  • These findings suggest that TFO and ODNas are viable candidates for the development of new anti-HBV therapeutics.
  • The observed lack of toxicity supports further investigation of these oligonucleotide-based strategies in preclinical and clinical settings.

More Related Videos

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...